CorTec Brain Interchange for Stroke
(MRPICS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial requires participants to stop taking anti-platelet medication for 7 days before and 3 days after the surgery. If you are on therapeutic anticoagulation or need other medications not mentioned, the clinical staff will decide if you can participate.
How is the CorTec Brain Interchange (BIC) System treatment for stroke different from other treatments?
The CorTec Brain Interchange (BIC) System is unique because it involves a brain-computer interface that can potentially provide real-time communication between the brain and external devices, which is not a feature of traditional stroke treatments. This system may offer a novel approach to restoring motor function by directly interacting with brain signals, unlike standard therapies that focus on physical rehabilitation or medication.12345
What is the purpose of this trial?
Using the CorTec Brain Interchange (BIC) System, we will examine the effect of a plasticity-inducing therapy regime on the rehabilitation of upper limb impairment post-stroke. This study's main objective is to implement and evaluate neuroplasticity-inducing stimulation. The stimulation methods for inducing neuroplasticity have been selected based on prior preclinical and intraoperative work that has shown promise in providing rehabilitative benefits for stroke patients. We will be structuring this study as an open prospective feasibility study.
Research Team
Jeffrey Ojemann
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for stroke survivors aged 22-75 with moderate upper limb impairment, who can engage in rehab and have had an ischemic cortical stroke at least 6 months ago. They must be able to visit the clinic for 54 weeks and show some motor response in their affected limb when tested.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive plasticity-inducing cortical stimulation therapy using the CorTec Brain Interchange system
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- CorTec Brain Interchange (BIC) System
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator